Latest Commercialization News

Fulcrum Lithium has unveiled promising geophysical survey results that significantly extend the known lithium claystone mineralisation at its Alkali Flats project in Nevada, setting the stage for an ambitious Phase 3 drilling campaign.

Streamplay Studio’s Winter Burrow has quickly generated over A$1.8 million in revenue days after its global release, driven by strong sales on Steam, Nintendo Switch, and Xbox Game Pass installs.

Terragen Holdings has secured a major purchase order from Mort & Co Fertilisers for its Great Land Plus® bio-stimulant, projecting a significant sales boost in 2026. This deal underscores growing demand for sustainable agricultural solutions.

Argent BioPharma has locked in an A$11 million convertible financing facility to finalize its strategic acquisition of AusCann assets and accelerate its growth plans, including a potential US stock exchange listing.

BPH Global Ltd has reported a record-breaking month in its Indonesian seaweed operations, more than doubling previous sales and advancing its export capabilities.

Genmin Limited has locked in A$25.7 million through a two-tranche placement, including significant director loan conversions, to advance its flagship Baniaka iron ore project towards production.

Adisyn Ltd has successfully validated a critical pre-clean sub-process in its proprietary low-temperature graphene deposition method, marking a significant technical milestone toward revolutionizing semiconductor interconnects.

Locksley Resources has partnered with Columbia University to develop cutting-edge, sustainable technologies for rare earth and critical mineral processing in the US, advancing its Mine-to-Market strategy amid growing government support.

Aurora Labs has entered a strategic MOU with Ares Armaments to co-develop advanced metal components for defence, aiming to revolutionise small-arms manufacturing with additive technology.

AnteoTech has achieved a breakthrough with its Ultranode™ X anode surpassing 1,000 charge cycles at 80% capacity retention, meeting key benchmarks for electric vehicle and eVTOL batteries. This milestone leverages cost-effective silicon materials, promising to reshape supply chains and accelerate market adoption.

Island Pharmaceuticals has secured FDA confirmation that its antiviral Galidesivir can proceed under the Animal Rule pathway for Marburg virus, qualifying for a lucrative Priority Review Voucher. This regulatory milestone accelerates the drug’s path to approval and potential government stockpile inclusion.

Algorae Pharmaceuticals has launched a Loyalty Options Offer, allowing eligible shareholders to purchase options at a nominal price, aiming to reward loyalty and support future growth funding.